Posts Tagged: cancer

CancerPathwayFinder_700x233

Liquid biopsy: a necessity in the age of personalized medicine

The 2001 introduction of Imatinib (Gleevec) for the treatment of chronic myelogenous leukemia was a watershed moment in cancer therapeutics. In addition to treating a previously fatal leukemia, it opened the door for the further development of targeted therapeutics, molecules designed to specifically inhibit individual oncogenic proteins. The advent of targeted therapy also made the… Read article →



targeted DNA sequencing

Targeted DNA sequencing: why you might miss some mutations

One of our favorite things here at QIAGEN is the concept of targeted DNA sequencing. If you haven’t heard about it yet, it’s an approach that involves enriching specific regions of a gene prior to NGS. More scientists have been adopting this strategy recently because it has three key advantages over whole-genome sequencing. Namely, targeted… Read article →



microRNA and lncRNA in lung cancer

miRNA and lncRNA – serum biomarkers for lung cancer

One of the most exciting potential applications of circulating non-coding RNAs like microRNA (miRNA) and long non-coding RNA (lncRNA) is as biomarkers for early detection of cancer. Cancer treatment, like treatment of many other diseases, can be far more effective when started early. Easily accessible markers like RNAs in the blood are an attractive possibility for finding… Read article →